4.4 Article

Role of functional magnetic resonance imaging in drug discovery

Journal

NEUROPSYCHOLOGY REVIEW
Volume 17, Issue 2, Pages 179-188

Publisher

SPRINGER
DOI: 10.1007/s11065-007-9023-0

Keywords

functional magnetic resonance imaging; drug development; anxiety; pharmacology; biomarkers

Funding

  1. NIMH NIH HHS [MH64122, MH075792, R01 MH075792-02, MH65413, R01 MH075792] Funding Source: Medline

Ask authors/readers for more resources

In this review, we survey the state of the field of functional magnetic resonance imaging (fMRI) as it relates to drug discovery and drug development. We highlight the advantages and limitations of fMRI for this purpose and suggest ways to improve the use of fMRI for developing new therapeutics, with emphasis on treatments for anxiety disorders. Fundamentally, pharmacological studies with standard psychiatric treatments using standardized behavioral probes during fMRI will need to be carried out to determine characteristic brain signatures that could be used to predict whether novel compounds are likely to have specific therapeutic effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available